About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Australian Government Department of Health, Disability and Ageing
New arrangements for nitisinone (Orfadin®) – Treatment of hereditary tyrosinaemia type 1 – information for patients
This fact sheet is for current and future patients with hereditary tyrosinaemia type 1 explaining how a treatment for this condition, nitisinone (Orfadin®), will be transitioning from the Life Saving Drugs Program to the PBS. It provides further clarity on future access arrangements via the PBS.